Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2005
12/15/2005US20050277604 Immunostimulatory nucleic acid molecules
12/15/2005US20050277603 Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
12/15/2005US20050277589 Linear cationic peptides having antibacterial and/or antifungal properties
12/15/2005US20050277575 Therapeutic compositions and methods for treating diseases that involve angiogenesis
12/15/2005US20050277194 Complementing cell lines
12/15/2005US20050277193 Vectors and methods for gene transfer
12/15/2005US20050277192 Hepatitis C virus nonstructural protein 4A (NS4A) is an enhancer element
12/15/2005US20050277183 Electroporation cuvette
12/15/2005US20050277178 Embedded expression of heterologous proteins
12/15/2005US20050277176 Human and mouse beta-defensins, antimicrobial peptides
12/15/2005US20050277174 Mutant tyrosine repressor, a gene encoding the same, and a method for producing L-DOPA
12/15/2005US20050277172 Novel variant hypocrea jecorina CBH1cellulases
12/15/2005US20050277165 Novel treatment
12/15/2005US20050277160 peptide or a phage recognizing nanographite structures and thus enabling efficient recognition, binding, separation and alignment of nanographite structures such as carbon nanohorns or carbon nanotubes, an artificial protein or a chimeric molecule comprising the above-described peptide bond
12/15/2005US20050277155 Method of immobilizing probes, in particular for producing biochips
12/15/2005US20050277152 Method for separation and purification of nucleic acid and unit for separation and purification of nucleic acid
12/15/2005US20050277151 NTR3, a novel member of the TNF- receptor supergene family
12/15/2005US20050277150 Compositions and methods for identifying agents which regulate autolytic processes in bacteria
12/15/2005US20050277149 Pharmaceutically tractable secondary drug targets, methods of identification and their use in the creation of small molecule therapeutics
12/15/2005US20050277146 Method of amplifying template DNA molecule using strand-displacing DNA polymerase capable of carrying out isothermal amplification
12/15/2005US20050277139 Methods and apparatus for the detection and validation of microRNAs
12/15/2005US20050277134 Method for amplifying nucleic acid and analysis of single-nucleotide polymorphism using the same
12/15/2005US20050277133 Study and interfererance, diagnosis and treatment of polyglutamine using short interfering nucleic acid for treatment of dementia or siezures or muscular dystrophy
12/15/2005US20050277124 Cardiac conduction system cells and uses thereof
12/15/2005US20050277121 Crude biological derivatives competent for nucleic acid detection
12/15/2005US20050277118 Methods for identifying subjects at risk of melanoma and treatments thereof
12/15/2005US20050277116 Compositions and methods for the identification of protein interactions in vertebrate cells
12/15/2005US20050276821 Antigen protein and nucleic acid coding for said protein
12/15/2005US20050276820 structural modification alters the biological persistence, preferably the biological half-life
12/15/2005US20050276819 Helicobacter pylori CAI antigen
12/15/2005US20050276817 Rhodococcus equi mutants and vaccines comprising same
12/15/2005US20050276809 comprising antibodies that specifically bind caspase-8 as inhibitors; cancer; activation of the receptor-interacting protein (RIP, a serine-threonine kinase) and Jun N-terminal kinase induce cell death with the morphology of autophagy
12/15/2005US20050276796 endowing a protein with bone-tissue targeting ability and improvement of its stability by means of addition of a short peptide consisting of acidic amino acids to the N-terminus of the protein; osteoporosis
12/15/2005US20050276789 Immunostimulatory oligonucleotides and uses thereof
12/15/2005US20050276788 Self-containing lactobacillus strain
12/15/2005US20050276787 Adeno-associated vector compositions for expression of factor VIII
12/15/2005US20050274612 Hybridization detecting unit including an electrode having depression parts and DNA chip including the detecting unit
12/15/2005DE102004026152A1 Fermentative Herstellung von Feinchemikalien Fermentative production of fine chemicals
12/15/2005DE10128980B4 Gen-modifizierte alloreaktive T-Zellen, Verfahren zu ihrer Herstellung und ihre Verwendung Gene-modified alloreactive T-cells, processes for their preparation and their use
12/15/2005CA2836987A1 Chimeric adenoviruses for use in cancer treatment
12/15/2005CA2776050A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2775886A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2742088A1 Antibodies that bind psca proteins for diagnosis of cancer
12/15/2005CA2572450A1 Methods and compositions involving microrna
12/15/2005CA2569183A1 Methods and compositions for the inhibition of gene expression
12/15/2005CA2568998A1 Polypeptides having dna polymerase activity
12/15/2005CA2568967A1 Agents and methods for diagnosing stress
12/15/2005CA2568838A1 Nucleic acids, polypeptides, methods of expression, and immunogenic compositions associated with sars corona virus spike protein
12/15/2005CA2568781A1 Intrathymic administration of viral vectors for the induction of immune tolerance, the prevention or treatment of immunodeficiencies or autoimmune diseases
12/15/2005CA2568780A1 Hepoxilins and modulators of ichthyin for treatment skin disorders
12/15/2005CA2568772A1 Expression system based on recombinant vesicular stomatitis virus synthesizing t7 rna polymerase
12/15/2005CA2568728A1 Improved 2-deoxy-d-ribose 5-phosphate aldolases (deras) and the uses thereof
12/15/2005CA2568689A1 Metabolically engineered cells for the production of polyunsaturated fatty acids
12/15/2005CA2568367A1 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/15/2005CA2568347A1 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/15/2005CA2568344A1 Novel artificial antigen presenting cells and uses therefor
12/15/2005CA2568222A1 Plants having improved growth characteristics and a method for making the same
12/15/2005CA2568162A1 Binding molecules capable of neutralizing rabies virus and uses thereof
12/15/2005CA2568161A1 A novel human card-only protein that inhibits pro-il-1beta maturation
12/15/2005CA2568026A1 Generation of plants with altered oil content
12/15/2005CA2568017A1 Generation of plants with altered oil content
12/15/2005CA2567983A1 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
12/15/2005CA2567978A1 Compositions and methods for synthesizing cdna
12/15/2005CA2567655A1 Binding moieties based on shark ignar domains
12/15/2005CA2567526A1 Cancer treatment method by inhibiting mage gene expression or function
12/15/2005CA2567491A1 Immune response assessment method
12/15/2005CA2567449A1 Antibodies and related molecules that bind to psca proteins
12/15/2005CA2567293A1 Methods for prediction of clinical outcome to epidermal growth factor receptor inhibitors by cancer patients
12/15/2005CA2567116A1 Enhancing protein expression
12/15/2005CA2567094A1 Chimeric adenoviruses for use in cancer treatment
12/15/2005CA2566868A1 A method for producing direct in vitro flowering and viable seed from cotyledon, radicle, and leaf explants and plants produced therefrom
12/15/2005CA2565685A1 Compositions and methods for enhancing delivery of nucleic acids into cells and for modifying expression of target genes in cells
12/15/2005CA2565524A1 Splice variant of unc5h2
12/15/2005CA2563930A1 Method for activating of t cell protein tyrosine phosphatase and therapeutical methods based thereon
12/15/2005CA2563721A1 Compositions and methods for producing libraries with controlled compositions and screening probabilites
12/15/2005CA2561861A1 Antibodies to angiogenesis inhibiting domains of cd148
12/14/2005EP1605261A1 Method of detecting colon cancer marker
12/14/2005EP1605063A1 Hybridization detecting unit and DNA chip including the detecting unit
12/14/2005EP1605062A1 Detection and quantification of micro-organisms using amplification and restriction enzyme analysis
12/14/2005EP1605061A1 Neisseria genomic sequences and methods of their use
12/14/2005EP1605058A1 Method of screening light chain of antibdoy
12/14/2005EP1605055A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/14/2005EP1605054A1 Method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same
12/14/2005EP1605053A1 Use of adenoviruses mutated in the VA genes for cancer treatment
12/14/2005EP1605052A2 A method for producing influenza hemagglutinin multivalent vaccines
12/14/2005EP1605051A2 Method for increasing transgene expression
12/14/2005EP1605050A2 Morphological mutants of filamentous fungi
12/14/2005EP1605049A2 Fibrinolytically active polypeptide
12/14/2005EP1605048A1 Engineering plant thioesterases and disclosure of plant thioesterases having novel substrate specificity
12/14/2005EP1605047A1 Chimeric and/or growth-restricted flaviviruses
12/14/2005EP1605046A1 Stably transfected cell lines expressing human GABA-A receptors with the subunit combination alpha-2, beta-3 and gamma-2
12/14/2005EP1605045A2 Polypeptides and nucleic acids encoding same
12/14/2005EP1605044A2 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker
12/14/2005EP1605043A1 Induction of methylation of cpg sequence by dsrna in mammalian cell
12/14/2005EP1605042A2 Compositions for protein fragment complementation assays to detect biomolecular interactions
12/14/2005EP1605040A1 Monocyte-origin multipotent cell momc
12/14/2005EP1604995A1 Novel guanosine derivatives and use thereof
12/14/2005EP1604688A1 Stabilised mRNA with increased G/C-content and optimised codon usage for gene therapy
12/14/2005EP1604668A1 Hepoxilins and modulators of ichthyin for treating skin disorders
12/14/2005EP1604044A1 Recovery of dna
1 ... 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 1913 1914 1915 1916 ... 4023